First Allied Advisory Services’s Albireo Pharma Inc ALBO Stock Holding History

First Allied Advisory Services’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-667	Closed	-$9K	–	1161
2015 Q3	$9K	Hold	667	–	–	﹤0.01%	1043
2015 Q2	$21K	Hold	667	–	–	﹤0.01%	1132
2015 Q1	$24K	Hold	667	–	–	﹤0.01%	1059
2014 Q4	$27K	Hold	667	–	–	﹤0.01%	1017
2014 Q3	$33K	Hold	667	–	–	﹤0.01%	1018
2014 Q2	$43K	Hold	667	–	–	﹤0.01%	967
2014 Q1	$55K	Hold	667	–	–	﹤0.01%	981
2013 Q4	$46K	Buy	667 +250	+60%	+$18.3K	﹤0.01%	928
2013 Q3	$40K	Buy	+417	New	+$54.3K	﹤0.01%	993

Other funds holding ALBO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

First Allied Advisory Services's ALBO Position: Q4 2015 in Review

First Allied Advisory Services sold out of Albireo Pharma Inc (ALBO) in Q4 2015, closing a stake of 667 shares — an estimated $9K sold.

First Allied Advisory Services first reported a position in ALBO in Q3 2013 and held it in 9 quarters. The position peaked at $55K in Q1 2014. 33 funds tracked by Wall St. Rank hold ALBO as of Q4 2015.

First Allied Advisory Services reported no remaining Albireo Pharma Inc position as of Q4 2015 after selling out during the quarter.
First Allied Advisory Services sold 667 Albireo Pharma Inc shares in Q4 2015, an estimated $9K.
First Allied Advisory Services first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 9 quarters.
First Allied Advisory Services's Albireo Pharma Inc position peaked at $55K in Q1 2014.
33 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2015.

Based on First Allied Advisory Services's 13F filing for Q4 2015, filed 16 Feb 2016.